Hiligsmann M, Dellaert BG, Dirksen CD, Watson V, Bours S, Goemaere S, Reginster JY, Roux C, McGowan B, Silke C, Whelan B, Diez-Perez A, Torres E, Papadakis G, Rizzoli R, Cooper C, Pearson G, Boonen A. Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment. Rheumatology (Oxford). 2017 Jul 1;56(7):1167-76. doi: 10.1093/rheumatology/kex071
Hifinger M, Hiligsmann M, Ramiro S, Severens JL, Fautrel B, Watson V, Boonen A. Patient's preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists. Rheumatology (Oxford). 2017 Jan;56(1):68-76. doi: 10.1093/rheumatology/kew328
Ray M, Goldstein S, Zhou S, Potamousis K, Sarkar D, Newton MA, Esterberg E, Kendziorski C, Bogler O, Schwartz DC. Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis. BMC genomics. 2013 Jul 26;14:505. doi: 10.1186/1471-2164-14-505
Han Y, Qin S, Wessler SR. Comparison of class 2 transposable elements at superfamily resolution reveals conserved and distinct features in cereal grass genomes. BMC genomics. 2013 Jan 31;14:71. doi: 10.1186/1471-2164-14-71
Keenan A-M, McKenna SP, Doward LC, Conaghan PC, Emery P, Tennant A. OAQoL: development and preliminary validation of a needs-based quality of life measure for osteoarthritis. Poster presented at the American College of Rheumatology 2007 Annual Scientific Meeting; April 2007. Chicago, IL. [abstract] Rheumatology (Oxford). 2007; 46:162-3.
Caro JJ, Ward A, Craig T, Huybrecht K, Arana A, Wait S, Eleftheriou A. Impact of thalassemia major on patients and their families. Acta Haematol. 2002;107(3):150-7.